Boston Scientific has partnered with Ireland-based CÚRAM, the SFI Research Centre for Medical Devices at National University Ireland (NUI) Galway, to advance medical devices for cardiovascular (CV) surgeries.
The partners plan to develop new devices that will support minimally invasive procedures performed to treat aneurysms and aortic valve repair.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Currently, valve repair procedures involving the use of a catheter to insert a replacement valve are being frequently performed and are said to minimise the risk of surgery for patients.
The new devices will be designed to further decrease this risk, while also improving patient outcomes.
Under the project, which will be led by CÚRAM principal investigator (PI) Dr Niamh Hynes, the organisations will combine their respective expertise and experience in clinical, biomedical and scientific research.
CÚRAM scientific director Abhay Pandit said: “This unique, multi-disciplinary, specialist environment is key to CÚRAM’s success in developing strong programmes of work with our industry partners; in this case bringing substantial investment from Boston Scientific.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“This project is in addition to three other ongoing research projects with Boston Scientific.”
The SFI Research Centre is also conducting a preclinical assessment of a catheter device to support muscle and vascular regeneration in critical limb ischemia.
In another project, CÚRAM and Boston Scientific have partnered to create a new implantable electrical stimulation device that will improve cardiovascular circulation.
Pandit added: “CÚRAM’s goal is to establish long-term strategic relationships with our industry partners, to complete projects that advance medical device technologies and inventions and convert these into products and services that benefit the patient.”
